Format

Send to

Choose Destination
Int J Clin Oncol. 2018 Feb;23(1):1-34. doi: 10.1007/s10147-017-1101-6. Epub 2017 Mar 27.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.

Author information

1
Department of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. toshwatanabe@yahoo.co.jp.
2
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
3
Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
4
Department of Surgery, Teikyo University, Tokyo, Japan.
5
Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
6
Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
7
Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
8
Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
9
Department of Translational Oncology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.
10
Department of Surgical Oncology, The Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
11
Colorectal Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
12
Department of Gastroenterology, St. Mary's Hospital, Fukuoka, Japan.
13
Department of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
14
Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
15
Radiation Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
16
Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
17
Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.
18
Department of Surgery, Kyoto University, Kyoto, Japan.
19
Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Takamatsu, Japan.
20
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
21
Department of Surgery, National Defense Medical College, Saitama, Japan.
22
Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
23
Department of Hemodialysis and Surgery, Chemotherapy Research Institute, International University of Health and Welfare, Ichikawa, Japan.
24
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
25
Diagnostic Pathology Center, Shinko Hospital, Kobe, Japan.
26
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
27
Department of Health Administration and Policy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
28
Department of Surgery, Cancer Center, Aomori Prefectural Central Hospital, Aomori, Japan.
29
Department of Surgery, Japanese Red Cross Kanazawa Hospital, Ishikawa, Japan.
30
CEO, Misawa City Hospital, Misawa, Japan.
31
Division of Clinical Oncolgy, Kochi Health Sciences Center, Kochi, Japan.
32
Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
33
Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
34
Division of GI Endoscopy, Kurume University School of Medicine, Fukuoka, Japan.
35
Department of Gastroenterological Surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
36
Library of SEIREI SAKURA Citizen Hospital, Sakura, Japan.
37
Department of Surgery, Tochigi Cancer Center, Utsunomiya, Japan.
38
Koujinkai Daiichi Hospital, Tokyo, Japan.

Abstract

Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many new treatment methods have been developed during recent decades. The Japanese Society for Cancer of the Colon and Rectum Guidelines 2016 for the treatment of colorectal cancer (JSCCR Guidelines 2016) were prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment, and to deepen mutual understanding between health-care professionals and patients by making these Guidelines available to the general public. These Guidelines were prepared by consensus reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches, and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these Guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. As a result of the discussions held by the Guideline Committee, controversial issues were selected as Clinical Questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here we present the English version of the JSCCR Guidelines 2016.

KEYWORDS:

Chemotherapy; Colorectal cancer; Endoscopy; Guideline; Radiotherapy; Surgery

PMID:
28349281
PMCID:
PMC5809573
DOI:
10.1007/s10147-017-1101-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center